000623: Jilin Aodong Pharmaceutical Group Co., Ltd. - Summary | Jitta

Jilin Aodong Pharmaceutical Group Co., Ltd.

CHN:000623

Price
CN¥18.87
Loss Chance
45.3%
4.86JITTA SCORE
28.41%Under Jitta Line
Jitta Ranking
24 / 487
216 / 5,259
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (52)
Recent Business Performance (82)
Financial Strength (79)
Return to Shareholders (18)
Competitive Advantage (28)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
CapExVery Low
Revenue and EarningRevenue decline from 2022-2025
Operating MarginDeclined
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.86
28.41%
4.42
> 1,000%
4.24
> 1,000%
Pharmaceuticals
6.36
2.64%
5.47
25.22%
7.76
43.10%
COMPANY DESCRIPTION
Jilin Aodong Pharmaceutical Group Co., Ltd. manufactures and sells pharmaceutical products in China. It provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat and water; wholesale, retail, and distribution of medicines; production and sale of packaging materials; and information consulting and advertising design and production activities. In addition, the company offers pharmaceutical excipients and packaging materials; produces and sells enzyme stock solutions; ginseng and antler products; sells health care products; and processes edible agricultural products, etc. Jilin Aodong Pharmaceutical Group Co., Ltd. was founded in 1957 and is based in Dunhua, China.